학술논문
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
Document Type
Article
Author
Mummery, C.J.; Börjesson-Hanson, A.; Blackburn, D.J.; Vijverberg, E.G.B.; De Deyn, P.P.; Ducharme, S.; Jonsson, M.; Schneider, A.; Rinne, J.O.; Ludolph, A.C.; Bodenschatz, R.; Kordasiewicz, H.; Swayze, E.E.; Fitzsimmons, B.; Mignon, L.; Moore, K.M.; Yun, C.; Baumann, T.; Li, D.; Norris, D.A.; Crean, R.; Bennett, C.F.; Junge, C.; Lane, R.M.; Graham, D.L.; Huang, E.; Ratti, E.
Source
In: Nature Medicine . (Nature Medicine, June 2023, 29(6):1437-1447)
Subject
Language
English
ISSN
1546170X
10788956
10788956